NetraMark Aktie

1,01 EUR +0,04 EUR +4,12 %

17.04.2025

STU

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Bei einem anderen Broker handeln Smartphone

Marktkap.77,62 Mio. EUR

Div. Rendite0,00%

WKNA3D5X9

ISINCA64119M1059

SymbolAINMF

NetraMark Aktien News

Sortieren:Datum Meistgelesen

10.04.25PR NewswireNETRAMARK TO HOST SHAREHOLDER CONFERENCE CALL TO DISCUSS BUSINESS MOMENTUM

04.04.25PR NewswireNETRAMARK UND WORLDWIDE CLINICAL TRIALS GEBEN VEREINBARUNG ZUR TRANSFORMATION DES KLINISCHEN STUDIENDESIGNS MIT KI-GESTÜTZTER PRÄZISION BEKANNT

03.04.25PR NewswireNETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION

10.03.25PR NewswireNETRAMARK STRENGTHENS FINANCIAL POSITION WITH ADDITIONAL $1,853,054 RAISED FROM WARRANT EXERCISE

05.03.25PR NewswireNETRAMARK UNVEILS AI DRIVEN INSIGHTS FOR MAJOR DEPRESSIVE DISORDER AND SCHIZOPHRENIA AT ISCTM CONFERENCE

05.03.25PR NewswireNETRAMARK PRÄSENTIERT AUF DER ISCTM-KONFERENZ NEUE KOGNITIVE ERKENNTNISSE ZUR BEHANDLUNG VON KLINISCHER DEPRESSION UND SCHIZOPHRENIE

25.02.25PR NewswireNETRAMARK AND THE ONTARIO BRAIN INSTITUTE PARTNER TO ADVANCE AI-POWERED NEUROANALYTICS FOR MAJOR DEPRESSION RESEARCH

24.02.25finanzen.netNetraMark legte Quartalsergebnis vor

19.02.25PR NewswireNETRAMARK TO PRESENT NOVEL AI-BASED CLINICAL TRIAL TREATMENT SEPARATION TOOLS AT ISCTM ANNUAL MEETING

18.02.25PR NewswireNETRAMARK TO PRESENT NOVEL AI-BASED CLINICAL TRIAL TREATMENT SEPARATION TOOLS AT ISCTM ANNUAL MEETING

12.02.25PR NewswireNETRAMARK LAUNCHES NETRAAI 2.0: ADVANCING CLINICAL TRIAL ANALYSIS WITH AI-POWERED INSIGHTS

04.02.25PR NewswireNETRAMARK PROVIDES BUSINESS UPDATE

24.01.25finanzen.netNetraMark mit Zahlen zum abgelaufenen Quartal

12.12.24PR NewswireNETRAMARK STRENGTHENS FINANCIAL POSITION WITH $1,161,000 RAISED FROM WARRANT AND STOCK OPTION EXERCISE

11.12.24PR NewswireNETRAMARK EXPANDS TEAM WITH THE ADDITION OF INDUSTRY VETERAN

09.12.24PR NewswireNETRAMARK SIGNS A PILOT COLLABORATION AGREEMENT WITH A TOP 5 PHARMACEUTICAL COMPANY

09.10.24PR NewswireONCOLOGY COMMERCIALIZATION LEADER P.J. HALEY TO JOIN NETRAMARK BOARD OF DIRECTORS

11.09.24PR NewswireNETRAMARK EXPANDS PRODUCT OFFERINGS TO ADDRESS CORE CLINICAL TRIAL CHALLENGES AND IMPROVE MARKET ACCESS SUCCESS

20.08.24PR NewswireNETRAMARK PROVIDES Q3 BUSINESS UPDATE AND HIGHLIGHTS PROGRESS

15.08.24finanzen.netNetraMark stellte Zahlen zum jüngsten Quartal vor

10.06.24PR NewswireNETRAMARK ANNOUNCES COLLABORATION AGREEMENT WITH NIMH TO ANALYZE CLINICAL TRIAL DATA ON THE USE OF KETAMINE IN PSYCHIATRIC DISORDERS

28.05.24PR NewswireNETRAMARK TO INTRODUCE THE TREATMENT ATTITUDE PROFILE (TAP™) SCALE FOR PLACEBO RESPONSE PERSONA DISCOVERY USING ITS NETRA AI TECHNOLOGY AT THE 2024 ASCP ANNUAL MEETING

15.05.24finanzen.netNetraMark präsentierte Quartalsergebnisse

10.04.24PR NewswireNETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES NOVEL LUNG AND COLON CANCER BIOMARKERS AND PATIENT SUBPOPULATIONS

05.04.24PR NewswireNETRAMARK ANNOUNCES SHAREHOLDER MEETING RESULTS

04.04.24PR NewswirePHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD

02.04.24PR NewswireNETRAMARK PROVIDES BUSINESS UPDATE AND HIGHLIGHTS PROGRESS

12.03.24PR NewswireNETRAMARK SIGNS CONTRACT WITH PHARMACEUTICAL COMPANY TO DELIVER CLINICAL TRIAL INSIGHTS REGARDING EFFICACY AND PLACEBO RESPONSE

11.03.24PR NewswireNETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES PARKINSON'S DISEASE SUBTYPES LINKED BY MITOCHONDRIAL, MICROBIOME AND IMMUNE SIGNALING

29.02.24PR NewswireNETRAMARK TO PRESENT NEW DATA HIGHLIGHTING THE UTILITY OF IT'S AI-BASED CLINICAL SOLUTION IN IDENTIFYING PARKINSON'S DISEASE ASSOCIATED BIOMARKERS AT AD/PD™ 2024

27.02.24PR NewswireNETRAMARK SIGNS FOURTH CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS

26.02.24PR NewswireNETRAMARK'S AI-BASED TECHNOLOGY IDENTIFIES SIGNIFICANT DRIVERS OF EFFICACY AND PLACEBO RESPONSES AND HAS POTENTIAL TO IMPROVE SUCCESS RATES FOR CLINICAL TRIALS OF PSYCHIATRIC MEDICATIONS

15.02.24PR NewswireNETRAMARK TO PRESENT NEW DATA DEMONSTRATING THE POWER OF ITS AI BASED TECHNOLOGY TO DE-RISK NEUROLOGY CLINICAL TRIALS AT ISCTM ANNUAL MEETING

12.02.24PR NewswireNETRAMARK ANNOUNCES LAUNCH OF THE NETRA AI LAB

30.01.24PR NewswireNETRAMARK SIGNS THIRD CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS

16.01.24PR NewswireNetraMark's Generative AI Discovers Novel Rare Disease Drug Targets and Unique Patient Subpopulations That Could Substantially Improve Clinical Trial Success Rates

20.12.23PR NewswireNETRAMARK SIGNS TWO CONTRACTS WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS

20.11.23PR NewswireNETRAMARK SELECTS FINN PARTNERS AS ITS PUBLIC RELATIONS AGENCY OF RECORD

NetraMark News

NetraMark News: auf dieser Seite finden Sie alle NetraMark News und Nachrichten zur NetraMark Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch NetraMark News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um NetraMark News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.